
The multiple myeloma landscape is evolving, with bispecific T-cell engagers offering hope.
The multiple myeloma landscape is evolving, with bispecific T-cell engagers offering hope.
Pharmacists have an important role in the optimization of AML therapies.
Published: April 7th 2025 | Updated: